Beesley et al. reported elevated activity of dipeptidyl peptidase IV (DPP-IV) in patients with different types of MPS and suggested it be used as a biomarker for MPS screening tests [13]. This evidence concerns the gene DPP4 and mucopolysaccharidosis.